Drospirenone induces the accumulation of triacylglycerides in the fish hepatoma cell line, PLHC-1

Drospirenone (DRO) is one of the most commonly used progestins reaching the aquatic environment through wastewater treatment plant effluents. It is a Progesterone Receptor Agonist, and as such, can act primarily in the brain and reproductive organs of fish. In order to better understand and predict its effects, this work evaluates the lipidomic changes induced in PLHC-1 cells after exposure to drospirenone at concentrations below the EC₁₀ (1 and 10 μM) by direct injection of the lipid extracts into a ESI(+/-) Orbitrap mass spectrometer. A significant accumulation of triacylglycerides, particularly long chain ones with unsaturated fatty acid moieties (TGs 46:2, 56:4-7; 58:5-8) and a concomitant decrease of diacylglycerides (DGs 32:1, 34:1-2, 36:1-2, 38:2-4) was observed after 48 h exposure to 10 μM DRO, which corresponded to an intracellular concentration of 8.3 ng·mg^-1 protein. No significant alteration of PLHC-1 cell lipids was observed following exposure to 1 μM DRO. EC₅₀ for the cytotoxicity of DRO ranged from 105 to 119 μM (24 h exposure) to 51-58 μM (48 h exposure). The study evidences a dysregulation of neutral lipid metabolism and increased TG/DG ratio in fish hepatic cells exposed to DRO.

Drospirenone; Lipidomics; Mass spectrometry; PLHC-1 cells.